November 4, 2021 Uncategorized

Prenetics 選擇 PacBio 的 Sequel IIe 為醫療護理建立個人化基因組學

加州門洛公園和香港, Nov. 04, 2021 (GLOBE NEWSWIRE) — PacBio 將向全球領先的基因組學和診斷測試公司 Prenetics Group Limited 提供高品質、高度準確的測序平台。該公司在香港、東南亞和英國增加了更全面的基因篩查服務，包括攜帶者篩查和癌症風險篩查。 Prenetics 行政總裁 Danny Yeung 表示：「隨著 CircleDNA 在全球為消費者取得成功，Circle Medical 將成為專供醫生專業服務的醫生專用產品。與 PacBio 的合作使我們能夠在消費者和臨床環境中擴大下一代測序技術的實用性和機會。」 Prenetics 臨床總監 Senthil Sundaram 醫學博士表示：「PacBio 的 SMRT HiFi 測序技術能夠在攜帶者篩查和癌症風險篩查中提供額外的基因資訊，我們很高興將這優勢帶給客戶和患者。」 PacBio 的技術將成為 Prenetics 的 Circle Medical 產品的關鍵組成部分，這是一種基因測試，旨在滿足醫生的診斷需求並提高檢測突變的準確性。Prenetics 還利用 PacBio 技術將表觀基因組學應用於終端消費者的產品，例如老齡、護膚和人口健康，以及用於醫療的產品，例如腸癌和肝癌。 PacBio 行政總裁 Christian Henry 表示：「這種合作夥伴關係體現了 PacBio SMRT 測序技術與世界頂級研究人員的創造力結合時的適應能力。Prenetics 已在全球內顯示出強勁的業務增長，我們很高興與他們密切合作，共同推動臨床基因組學的下一階段增長。」 PacBio 科學總監 Jonas Korlach... Read more

November 4, 2021 Uncategorized

[Ad hoc announcement pursuant to Art. 53 LR] Roche announces the repurchase of the equity stake held by Novartis in Roche

Roche and Novartis agree on the repurchase by Roche Holding Ltd of 53.3 million Roche shares from Novartis Holding AG. Repurchase is conditional upon the approval of a capital reduction by cancellation of the repurchased shares and the approval of the interim financial statements prepared for the purpose of the transaction by an Extraordinary General... Read more

November 3, 2021 Uncategorized

PacBio’s Sequel IIe Selected by Prenetics to Build Personalized Genomics for Healthcare

MENLO PARK, Calif. and HONG KONG, Nov. 03, 2021 (GLOBE NEWSWIRE) — PacBio will be providing its high-quality, highly accurate sequencing platforms to Prenetics Group Limited, a leading global genomics and diagnostic testing company, as the firm adds more comprehensive genetic screening services including carrier screening and cancer-risk screening in Hong Kong, Southeast Asia and... Read more

November 2, 2021 Environ, Ag./Food & Bev Lab Top-10 PAI Top-10 PR/Corporate

PerkinElmer Announces Financial Results for the Third Quarter of 2021

Revenue of $1.17 billion; 21% reported growth; 12% organic growth GAAP EPS from continuing operations of $1.11; Adjusted EPS of $2.31 Initiates Fourth Quarter Guidance and Raises Full Year Revenue and Earnings Guidance WALTHAM, Mass.–(BUSINESS WIRE)–Nov. 2, 2021– PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today reported financial... Read more

November 2, 2021 PAI Top-10 PR/Corporate

PacBio Announces Third Quarter 2021 Financial Results

MENLO PARK, Calif., Nov. 02, 2021 (GLOBE NEWSWIRE) — PacBio (NASDAQ: PACB) today announced financial results for the quarter ended September 30, 2021. Record revenue reflects 6th straight quarter of sequential growth Revenue of $34.9 million, an 83% increase compared with $19.1 million in the prior year period. Placed 44 Sequel II/IIe systems during the... Read more

November 2, 2021 Uncategorized

PacBio’s Sequel IIe Selected by Prenetics to Build Personalized Genomics for Healthcare

MENLO PARK, Calif. and HONG KONG, Nov. 02, 2021 (GLOBE NEWSWIRE) — PacBio will be providing its high-quality, highly accurate sequencing platforms to Prenetics Group Limited, a leading global genomics and diagnostic testing company, as the firm adds more comprehensive genetic screening services including carrier screening and cancer-risk screening in Hong Kong, Southeast Asia and... Read more

November 2, 2021 Lab Top-10 PR/Corporate

Thermo Fisher Scientific Showcases Investment and Innovation During CPhI Worldwide 2021

Thermo Fisher Scientific Showcases Investment and Innovation During CPhI Worldwide 2021 Strategic expansions help to enable accelerated demand for new medicines and therapies WALTHAM, Mass., Nov. 2, 2021 /PRNewswire/ — At CPhI Worldwide 2021, Thermo Fisher Scientific will showcase its newest capabilities across its global pharma services network which help pharmaceutical and emerging biotech companies accelerate... Read more

November 2, 2021 Lab Top-10 Liq. Handling & Robotics

Bruker Announces Major Advances in CCS-Enabled 4D Proteomics at ASMS

Bruker PaSER™ software now incorporates transformative CCS-enabled DIA-NN deep neural network learning with breakthrough dia-PASEF capabilities to identify: >8000 quantified cell lysate proteins with 40-minute gradients >5000 quantified cell lysate proteins with 4.8-minute separations on Evosep One >5000 quantified proteins in just 10 ng of cell lysate digest with 95-minute gradients Work-in-progress CCS-enabled ‘prm Live’... Read more